Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2005
10/06/2005US20050221434 Receptor of the EDb-fibronectin domains
10/06/2005US20050221432 Altering the cellular secretion rate of a protein comprising the steps of modulating the activity of at least one UPR pathway component in a cell and culturing the cell; useful for producing high levels of proteins for therapeutic, diagnostic or research purposes
10/06/2005US20050221430 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
10/06/2005US20050221423 Bacillus host cell
10/06/2005US20050221421 Method of producing and using heat shock proteins
10/06/2005US20050221420 Nogo receptor homologues and their use
10/06/2005US20050221394 Ion channel
10/06/2005US20050221393 Method of increasing product expression through solute stress
10/06/2005US20050221372 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
10/06/2005US20050221356 Process for producing ligand binding protein with the use of cell-free protein synthesis system and utilization thereof
10/06/2005US20050221352 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/06/2005US20050221344 Interferon-Like molecules and uses thereof
10/06/2005US20050221343 Self-assembling split-fluorescent protein systems
10/06/2005US20050221340 Computer-directed assembly of a polynucleotide encoding a target polypetide
10/06/2005US20050221308 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state
10/06/2005US20050221303 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/06/2005US20050221298 Anti-idiotypic antibody and its use in diagnosis and therapy in HIV-related disease
10/06/2005US20050221296 Comprises peptide for genotyping and detecting hepatitis viral infection; immunoassay; antigenic peptides of HCV immobilized on solid substrate
10/06/2005US20050221284 Heteropolymer complexes and methods for their use
10/06/2005US20050220938 Method for manufacturing proteoses derived from animal protein and manufacturing food containing the proteoses
10/06/2005US20050220807 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/06/2005US20050220805 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines
10/06/2005US20050220797 Prophylactic and therapeutic monoclonal antibodies
10/06/2005US20050220790 Amino-terminally truncated rantes as chemokine antagonists
10/06/2005US20050220789 T cell immune response cDNA 7 (TIRC7) protein for use in treatment of organ transplantation rejection, tumor, autoimmune and/or allergic disorders
10/06/2005US20050220757 Chemokine mutants acting as chemokine antagonists
10/06/2005CA2561502A1 Marker gene for arthrorheumatism test
10/06/2005CA2561495A1 Truncated dance, dance complex and method of using these
10/06/2005CA2560593A1 Exo-endo cellulase fusion protein
10/06/2005CA2560588A1 Cellulase fusion protein and heterologous cellulase fusion construct encoding the same
10/06/2005CA2556221A1 Development and use of fluorescent probes of unbound analytes
10/05/2005EP1582582A1 CELL EXTRACT OF i ESCHERICHIA COLI /i HAVING MUTATION IN S12 RIBOSOMAL PROTEIN AND PROCESS FOR PRODUCING PROTEIN IN CELL-FREE SYSTEM USING THE SAME
10/05/2005EP1581797A2 Methods for the detection, analysis and isolation of nascent proteins
10/05/2005EP1581644A1 Purification of polypeptides
10/05/2005EP1581623A2 Trefoil domain-containing polypeptides and uses thereof
10/05/2005EP1581618A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/05/2005EP1581616A2 Novel proteins and nucleic acids encoding same
10/05/2005EP1581552A2 Human and non-human primate homologues of nkd protein, nucleic acid sequences encoding, and uses thereof
10/05/2005CN1678756A Metalized polyester film with heat-seal layer on opposite side for flyback transformer application
10/05/2005CN1678752A Analytical method for the determination of infant formula protein digestibility in vitro
10/05/2005CN1678742A Novel aldolase and production process of substituted alpha-keto acids
10/05/2005CN1678740A Antibody against N-terminal peptide or C-terminal peptide of GPC3 solubilized in blood
10/05/2005CN1678735A Cloning and sequencing of pyruvate decarboxylase (PDC) genes from bacteria and uses therefor
10/05/2005CN1678633A Anti-IGF-I receptor antibody
10/05/2005CN1678630A HCV fusion proteins with modified NS3 domains
10/05/2005CN1678628A Stress proteins and peptides and methods of use thereof
10/05/2005CN1678624A Benzoate- and anthranilate-inducible promoters
10/05/2005CN1678347A Antibodies and uses thereof
10/05/2005CN1678343A Use of escherichia coli heat labile toxin as an adjuvant in birds and poultry
10/05/2005CN1676610A Novel penicillium marneffei PPIase II, its coding sequence and use
10/05/2005CN1676609A Novel penicillium marnffei PPIase II, its coding sequence and use
10/05/2005CN1676608A Novel penicillium marneffei ERG1 gene, its coding protein and use
10/05/2005CN1676606A Method for reconstructing target protein from protein segment in plant
10/05/2005CN1676600A Genetically engineered bacteria for efficiently expressing recombinant human sweet gland antibacterial peptide, and its constructing method and use
10/05/2005CN1221665C Use of negative regulation elements for nerve-specific expression of transgenes
10/05/2005CN1221569C Cell surface molecule mediating cell adhesion and signal transmission
10/05/2005CN1221567C Technological process of producing recombinant human tissue type plasminogen activator TNK mutant
10/05/2005CN1221566C gClq receptor jointed HIV-lgp120 relative peptide and coded oligonucleotide thereof
10/04/2005US6951923 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy
10/04/2005US6951922 Antibodies immunologically reactive with broad-spectrum delta endotoxins
10/04/2005US6951752 Method for large scale production of virus antigen
10/04/2005US6951742 Polyclonal and monoclonal antibodies to antigens in poultry or birds, formed using polynucleotide vaccines; proteomics
10/04/2005US6951741 Host/vector system for expression of membrane proteins
10/04/2005US6951740 Comprises expression vector for transfection and expression of thrombopoietin in cell; bioreactors and heterologous polypeptide expression
10/04/2005US6951737 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/04/2005US6951735 Death domain containing receptors
10/04/2005US6951734 Generate protein for X-ray crystallographic analysis; obtain cell extract, incubate with protein synthesis mixture and label, detect signal from preferential protein
10/04/2005US6951646 recognizing conformation dependent epitopes of HCV glycoprotein E2 that are capable of neutralizing the binding of E2 protein onto susceptible cells
09/2005
09/29/2005WO2005090566A2 Ligational encoding using building block oligonucleotides
09/29/2005WO2005090552A2 Method of engineering a cytidine monophosphate-sialic acid synthetic pathway in fungi and yeast
09/29/2005WO2005090405A1 Subtype of humanized antibody against interleukin-6 receptor
09/29/2005WO2005090399A1 Antibody recognizing the proliferation/differentiation of various types of cells and method of evaluating proliferation/differentiation by using the antibody
09/29/2005WO2005090384A1 Substances k01-0509 and process for producing the same
09/29/2005WO2005089799A1 Cytotoxicity method using effector function of anti-fam3d antibody
09/29/2005WO2005089285A2 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
09/29/2005WO2005089182A2 Improved bacterial host cell for the direct expression of peptides
09/29/2005WO2005089047A2 Glycosylated glucocerebrosidase expression in fungal hosts
09/29/2005WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof
09/29/2005WO2005056752A3 Methods and compositions for delivering polynucleotides
09/29/2005WO2005051985A3 Methods for purifying pertussis toxin and peptides useful therefor
09/29/2005WO2005023205A3 Compositions and methods for yersinia pestis treatment
09/29/2005WO2005007820A3 Activated protein c variants with normal cytoprotective activity but reduced anticoagulant activity
09/29/2005WO2005007674A3 Anti-human vitronectin antibody and methods for making the same
09/29/2005WO2004101737A3 A novel adjuvant capable of specifically activating the adaptive immune response
09/29/2005WO2004099332A3 Wood adhesives containing solid residues of biomass fermentations
09/29/2005WO2003076469A9 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
09/29/2005US20050216963 Prion-free transgenic ungulates
09/29/2005US20050216958 Fucosyltransferase knock-out host cell for use as bioreactors in production of preferentially modified glycoproteins
09/29/2005US20050215775 70 human secreted proteins
09/29/2005US20050215766 Allergen from mugwort pollen
09/29/2005US20050215502 Regulation of endogenous gene expression in cells using zinc finger proteins
09/29/2005US20050215467 Multimeric Apo A-I agonist compounds
09/29/2005US20050214937 Surface proteins of leptospira
09/29/2005US20050214910 Chordin-like molecules and uses thereof
09/29/2005US20050214906 Means and methods for regulating gene expression
09/29/2005US20050214905 Novel compounds
09/29/2005US20050214900 Enzyme/tag binding and detection system
09/29/2005US20050214899 Capable of removing the N-terminal Met from bulky or acidic penultimate residues
09/29/2005US20050214890 Novel "Cleave-N-Read" system for protease activity assay and methods of use thereof
09/29/2005US20050214861 Human hematopoietic stem and progenitor antigen and methods for its use